P535: Outcomes of endoscopic resections of large non-polypoid lesions inflammatory bowel disease: a single United Kingdom centre experienceECCO '17 Barcelona
2017
P536: Combination therapy of bone marrow mesenchymal stromal cells and azathioprine not affect the clinical course luminal Crohn's diseaseECCO '17 Barcelona
2017
P537: Is anti-TNF therapeutic drug monitoring of value in IBD patients in clinical remission?ECCO '17 Barcelona
2017
P538: Can enteral polymeric diet change the post-surgical outcome in Crohn's disease patients? A pilot studyECCO '17 Barcelona
2017
P539: Does a change in therapeutic approach modify outcome in IBD patients? A comparison between two cohorts 2004–2007 and 2010–2013ECCO '17 Barcelona
2017
P540: Efficacy of granulocyte and monocyte apheresis for antibiotic-refractory pouchitis after proctocolectomy for ulcerative colitis: an open-label, prospective, multicentre studyECCO '17 Barcelona
2017
P541: Intestinal failure: a rare but significant outcome of restorative proctocolectomyECCO '17 Barcelona
2017
P542: Long-term outcomes after switching from originator infliximab to biosimilar in paediatric-onset inflammatory bowel disease patients: a single centre prospective observational studyECCO '17 Barcelona
2017
P543: Structured transition enhances clinical outcome without an increase in healthcare cost in adolescent patients with IBD: the UK TRANSIT studyECCO '17 Barcelona
2017
P544: Combination therapy of vedolizumab and a TNF antagonist in IBD patients with severe chronic active, therapy refractory disease courseECCO '17 Barcelona
2017
P545: Clinical outcomes following a switch from Remicade® to the biosimilar CT-P13 in inflammatory bowel disease patients in clinical remission: preliminary resultsECCO '17 Barcelona
2017
P546: Which are the optimal adalimumab trough levels associated with biological remission in patients with inflammatory bowel disease?ECCO '17 Barcelona
2017
P548: Hepatitis B virus reactivation in hepatitis B virus infected patients with inflammatory bowel disease receiving anti-tumor necrosis factor-alpha therapyECCO '17 Barcelona
2017
P549: Effect of maintenance Ustekinumab on corticosteroid-free clinical outcomes in patients with Crohn's diseaseECCO '17 Barcelona
2017
P552: An online educational portal improves concerns of inflammatory bowel disease patients regarding pregnancy and medicationECCO '17 Barcelona
2017
P553: Long-term outcomes of seton drainage for perianal fistulizing Crohn's diseaseECCO '17 Barcelona
2017